Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD

0.7196  +0 (+0.22%)

Fundamental Rating

3

DRIO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. The financial health of DRIO is average, but there are quite some concerns on its profitability. DRIO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DRIO has reported negative net income.
In the past year DRIO has reported a negative cash flow from operations.
In the past 5 years DRIO always reported negative net income.
In the past 5 years DRIO always reported negative operating cash flow.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

DRIO has a Return On Assets of -34.47%. This is in the lower half of the industry: DRIO underperforms 67.57% of its industry peers.
With a Return On Equity value of -56.90%, DRIO perfoms like the industry average, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
ROA -34.47%
ROE -56.9%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

DRIO has a Gross Margin of 49.06%. This is comparable to the rest of the industry: DRIO outperforms 45.95% of its industry peers.
In the last couple of years the Gross Margin of DRIO has grown nicely.
The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DRIO has more shares outstanding
DRIO has a better debt/assets ratio than last year.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DRIO has an Altman-Z score of -5.30. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DRIO (-5.30) is worse than 67.57% of its industry peers.
DRIO has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
DRIO has a Debt to Equity ratio (0.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -5.3
ROIC/WACCN/A
WACC13.06%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

DRIO has a Current Ratio of 2.44. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.44, DRIO is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
DRIO has a Quick Ratio of 2.15. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
DRIO has a better Quick ratio (2.15) than 62.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.15
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

DRIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.36%, which is quite impressive.
DRIO shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.86%.
The Revenue has been growing by 29.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)68.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)32.86%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%17.26%

3.2 Future

DRIO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.06% yearly.
DRIO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.58% yearly.
EPS Next Y41.32%
EPS Next 2Y24.29%
EPS Next 3Y24.24%
EPS Next 5Y15.06%
Revenue Next Year15.19%
Revenue Next 2Y18.51%
Revenue Next 3Y19.88%
Revenue Next 5Y20.58%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

DRIO's earnings are expected to grow with 24.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.29%
EPS Next 3Y24.24%

More info and screens

0

5. Dividend

5.1 Amount

DRIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (5/23/2025, 9:28:34 PM)

0.7196

+0 (+0.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners29.96%
Inst Owner Change-5.09%
Ins Owners8.82%
Ins Owner Change6.65%
Market Cap31.63M
Analysts82.22
Price Target2.72 (277.99%)
Short Float %8.27%
Short Ratio10.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.93%
Min EPS beat(2)10.33%
Max EPS beat(2)73.53%
EPS beat(4)4
Avg EPS beat(4)55.33%
Min EPS beat(4)10.33%
Max EPS beat(4)85.87%
EPS beat(8)6
Avg EPS beat(8)28.85%
EPS beat(12)9
Avg EPS beat(12)24.52%
EPS beat(16)10
Avg EPS beat(16)16.83%
Revenue beat(2)1
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.92%
Revenue beat(4)1
Avg Revenue beat(4)-9.92%
Min Revenue beat(4)-22.51%
Max Revenue beat(4)0.92%
Revenue beat(8)2
Avg Revenue beat(8)-9.89%
Revenue beat(12)5
Avg Revenue beat(12)-6.7%
Revenue beat(16)6
Avg Revenue beat(16)-6.04%
PT rev (1m)0%
PT rev (3m)-23.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)51.39%
EPS NY rev (1m)-7%
EPS NY rev (3m)64.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)97.49%
Revenue NY rev (1m)-4.79%
Revenue NY rev (3m)-13.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS0.62
BVpS1.64
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.47%
ROE -56.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.06%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.86%
Cap/Sales 0.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 2.15
Altman-Z -5.3
F-Score5
WACC13.06%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y41.32%
EPS Next 2Y24.29%
EPS Next 3Y24.24%
EPS Next 5Y15.06%
Revenue 1Y (TTM)32.86%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%17.26%
Revenue Next Year15.19%
Revenue Next 2Y18.51%
Revenue Next 3Y19.88%
Revenue Next 5Y20.58%
EBIT growth 1Y-1.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year69.26%
EBIT Next 3Y25.08%
EBIT Next 5Y15.81%
FCF growth 1Y-24.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.94%
OCF growth 3YN/A
OCF growth 5YN/A